Patents by Inventor Dov Diller

Dov Diller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040058955
    Abstract: The present invention provides novel crystal forms of fexofenadine hydrochloride Forms V, VI and VIII through XV and processes for their preparation and preparation of amorphous form and other crystalline forms of fexofenadine hydrochloride. Forms XIV and XV are solvates of ethyl acetate, while Form IX is anhydrous, but can be crystallized as a solvate of MTBE or cyclohexane. The forms are useful for administration to humans and animals to alleviate symptoms caused by histamine. The present invention further provides pharmaceutical compositions of the new crystalline forms.
    Type: Application
    Filed: September 12, 2003
    Publication date: March 25, 2004
    Inventors: Ben-Zon Dolitzky, Shlomit Wizel, Barnaba Krochmal, Dov Diller, Irwin Gross
  • Publication number: 20040044038
    Abstract: Provided is a crystalline (polymorphic) form of fexofenadine hydrochloride, denominated fexofenadine hydrochloride Form XVI.
    Type: Application
    Filed: June 10, 2003
    Publication date: March 4, 2004
    Inventors: Barnaba Krochmal, Dov Diller, Ben-Zion Dolitzky, Judith Aronhime, Shlomit Wizel, Boaz Gome, Igor Lifshitz
  • Publication number: 20030158227
    Abstract: The present invention provides novel crystal forms of fexofenadine base and processes for their preparation. The forms are useful for administration to humans and animals to alleviate symptoms caused by histamine. The present invention further provides pharmaceutical compositions of the new crystalline forms.
    Type: Application
    Filed: November 8, 2002
    Publication date: August 21, 2003
    Inventors: Barnaba Krochmal, Dov Diller, Ben-Zion Dolitzky, Judith Aronhime, Shlomit Wizel
  • Publication number: 20030021849
    Abstract: The present invention provides novel crystal forms of fexofenadine hydrochloride Forms V, VI and VIII through XV and processes for their preparation and preparation of amorphous form and other crystalline forms of fexofenadine hydrochloride. Forms XIV and XV are solvates of ethyl acetate, while Form IX is a solvate of MTBE or cyclohexane. The forms are useful for administration to humans and animals to alleviate symptoms caused by histamine. The present invention further provides pharmaceutical compositions of the new crystalline forms.
    Type: Application
    Filed: April 26, 2002
    Publication date: January 30, 2003
    Inventors: Ben-Zion Dolitzky, Shlomit Wizel, Barnaba Krochmal, Dov Diller, Irwin Gross
  • Publication number: 20020177608
    Abstract: The present invention provides novel crystal forms of fexofenadine hydrochloride Forms V, VI and VIII through XV and processes for their preparation and preparation of amorphous form and other crystalline forms of fexofenadine hydrochloride. Forms XIV and XV are solvates of ethyl acetate, while Form IX is anhydrous, but can be crystallized as a solvate of MTBE or cyclohexane. The forms are useful for administration to humans and animals to alleviate symptoms caused by histamine. The present invention further provides pharmaceutical compositions of the new crystalline forms.
    Type: Application
    Filed: April 8, 2002
    Publication date: November 28, 2002
    Inventors: Ben-Zion Dolitzky, Shlomit Wizel, Barnaba Krochmal, Dov Diller, Irwin Gross
  • Publication number: 20020115673
    Abstract: The present invention is directed to the novel forms of risperidone, designated Form A, Form B and Form E. Methods for their preparation are also disclosed. The present invention also relates to processes for making risperidone. Pharmaceutical compositions containing the new forms of risperidone and methods of using them are also disclosed.
    Type: Application
    Filed: August 14, 2001
    Publication date: August 22, 2002
    Inventors: Barnaba Krochmal, Dov Diller, Ben-Zion Dolitzky
  • Publication number: 20020115672
    Abstract: The present invention is directed to the novel forms of risperidone, designated Form A, Form B and Form E. Methods for their preparation are also disclosed. The present invention also relates to processes for making risperidone. Pharmaceutical compositions containing the new forms of risperidone and methods of using them are also disclosed.
    Type: Application
    Filed: August 8, 2001
    Publication date: August 22, 2002
    Inventors: Barnaba Krochmal, Dov Diller, Ben-Zion Dolitzky, Judith Aronhime